Search results

Frequently asked questions about the ANSTO Security Process, travel funding, ANSTO Research Portal and ACNS Customer Portal.

Sample environments, Data analysis, SpICE and SICS

Frequently asked questions about beamtime, accommodation and the user portal.

The Public Interest Disclosure Act 2013 aims to promote integrity and accountability in the Australian Public Sector by encouraging the disclosure of information about actual or suspected wrongdoing, protecting people who make disclosures and ensuring that disclosures are properly investigated and dealt with.

ANSTO provides eduroam services for partnering institutions in Australia and around the world.

Frequently Asked Questions on the Macromolecular Crystallography beamlines (MX1 and MX2)

ANSTO's Graduate Program develops the next generation of Australian business and science leaders, by providing the best and brightest postgraduate students with a two-year rotation cycle, tailored to match your talents, goals and interests.

Sample environments, Data Analysis, Mail-In Services

Sample environments, Data analysis.

Voucher scheme accelerating medical research

The Australian Synchrotron provides funding support for successful beamtime applicants in the form of travel funding and/or onsite accommodation. Travel funds granted are to be used solely to cover the majority of the cost to travel to the AS facility. The User Office will book accommodation for interstate user groups at the onsite AS Guesthouse.

COVID-19 can’t stop kids with a passion for science and technology, with ANSTO launching our new online STEAM Club just in time for the school holidays.

The Macromolecular Crystallography beamlines at the Australian Synchrotron (MX1 and MX2) are general purpose crystallography instruments for determining chemical and biological structures.

ANSTO’s user office in Melbourne offers access to the Australian Synchrotron, a world-class research facility with over 4,000 user visits per year. ANSTO seeks collaboration and partnerships with research organisations, scientific users and commercial users.